AB 1778 California Assembly · 2025-2026 Regular Session

Controlled substances: testosterone.

Summary

Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 designated schedules, with the most restrictive limitations generally placed on controlled substances classified in Schedule I, and the least restrictive limitations generally placed on controlled substances classified in Schedule V. Existing federal law also regulates controlled substances by schedule. Under existing state and federal law, testosterone is classified as a Schedule III controlled substance. This bill would, if testosterone or dihydrotestosterone is excluded from Schedule III of the federal Controlled Substances Act and reclassified to a less restrictive schedule or exempted from the act, deem it to be rescheduled or exempted, respectively, under this division.

Bill status signed all 5 stages cleared

Introduction

Feb 2026

Committee Review

Jun 2026

Assembly Passage

May 2026

Senate Passage

Jul 2026

Signed into Law

Aug 2026

Introduced Feb 9, 2026 Signed Aug 24, 2026

Maddy AI version diff · 4 comparisons

What changed between versions

08/24/26 - Chaptered → AB1778 · 1 edit

MINOR

No substantive policy changes were made between these two versions. The difference is purely presentational: the first version is the clean chaptered text of the enrolled bill, while the second is a web page rendering from the California Legislature website that includes navigation menus, headers, and formatting artifacts. The actual legislative content - adding Section 11056.5 to the Health and Safety Code to automatically conform testosterone and dihydrotestosterone scheduling to federal law if it becomes less restrictive - is identical in both.

TECHNICAL

The document changed from a clean chaptered text format to a web page rendering of the same bill, adding navigation elements (home, FAQ, login, search bars) and website formatting. No policy language was altered.

Floor votes · Senate Jul 2, 2026 · Assembly May 14, 2026

How they voted

37–0

Passed · 3 other

Total votes 40

Jul 2, 2026

D Democratic30

28 Yea 2

93% Yea

R Republican10

9 Yea 1

90% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Aug 24, 2026

Signed into law

Approved by the Governor.

legislature

Aug 6, 2026

Lower · Passed

Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 75. Noes 0. Page 6073.).

lower

Jul 2, 2026

Introduced

In Assembly. Concurrence in Senate amendments pending.

lower

Jul 2, 2026

Upper · Passed

Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0.).

upper

Jun 29, 2026

Upper · Passed

From committee: Be ordered to second reading file pursuant to Senate Rule 28.8 and ordered to Consent Calendar.

upper

Jun 16, 2026

Upper · Passed

From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 6. Noes 0.) (June 16). Re-referred to Com. on APPR.

upper

Jun 1, 2026

Introduced

From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on PUB. S.

upper

May 27, 2026

Committee

Referred to Com. on PUB. S.

upper

May 14, 2026

Lower · Passed

Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 5053.)

lower

May 6, 2026

Lower · Passed

From committee: Do pass. To Consent Calendar. (Ayes 14. Noes 0.) (May 6).

lower

Apr 22, 2026

Lower · Passed

From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 9. Noes 0.) (April 21). Re-referred to Com. on APPR.

lower

Apr 7, 2026

Lower · Passed

From committee: Do pass and re-refer to Com. on PUB. S. with recommendation: To Consent Calendar. (Ayes 19. Noes 0.) (April 7). Re-referred to Com. on PUB. S.

lower

Mar 2, 2026

Committee

Referred to Coms. on B. & P. and PUB. S.

lower

Feb 10, 2026

Lower · Passed

From printer. May be heard in committee March 12.

lower

1 primary · 0 co-sponsors